pharmaphorum| News & views on pharma and biotech’s evolving future

R&D

An elderly woman holds her hand to stop shaking

Parkinson’s Awareness Month may end, but the research impera...

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.

News

Graphic representation of team assessing bar graphs and pie charts

Lilly falls on slower start for Foundayo versus Wegovy

Sky-high expectations for sales of Eli Lilly's new oral GLP-1 agonist Foundayo have been dented by preliminary sales data from IQVIA.

R&D

GLP-1 pricing and supply: Examining the signals behind the n...

News

New NIHR-funded TRC for Parkinson’s disease

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

News

Four hands, each with a puzzle piece, coming together in the centre

Sun sets out $11.75bn takeover play for Organon

After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.

Featured Content

Sales & Marketing

Changing Faces: Agency, consultancy, and investor, March 202...

March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.

R&D

GLP-1 pricing and supply: Examining the signals behind the n...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

R&D

From obesity to outcomes abstract visual

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

R&D

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Newsletters and Deep Dive
digital magazine

Latest News

News

Lilly falls on slower start for Foundayo versus Wegovy

Sky-high expectations for sales of Eli Lilly's new oral GLP-1 agonist Foundayo have been dented by preliminary sales data from IQVIA.

News

New NIHR-funded TRC for Parkinson’s disease

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

News

Sun sets out $11.75bn takeover play for Organon

After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.

News

FDA grants three priority vouchers to psychedelics

The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.

Views & Analysis

Sales & Marketing

Changing Faces: Agency, consultancy, and investor, March 202...

March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.

Market Access

The companies shaping the UK’s commercial landscape

Which companies are working with the government to implement the US-UK pharmaceutical trade agreement?

R&D

Parkinson’s Awareness Month may end, but the research impera...

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater.

R&D

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

Deep Dive

R&D

The GLP-1 Reckoning

R&D

Redesigning obesity trials for a chronic disease era

R&D

GLP-1s: Five years that changed metabolic medicine

R&D

The trust gap: GLP-1s and the new information economy of obe...

White Papers & Webinar

R&D

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Sales & Marketing

Sponsored

What HCPs Say Pharma Gets Wrong About Survey Research

Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Podcasts & Video

Patients

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

R&D

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

Sales & Marketing

Sponsored

Pushing through barriers to commercial launch success, with ...

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

Patients

pharmaphorum podcast Episode 254, Thomas Goetz, Drug Story

Every drug is a story, with Thomas Goetz

Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.

Partner Content

Press Releases

Partner Content

Navigating Change: Key Industry Insights at PHARMAP 2026

PHARMAP returns in 2027 in Berlin, Germany, with Bayer as the Host Sponsor

Press Releases

Partner Content

Axtria Acquires Conexus Solutions, Uniting Agentic AI and CR...

Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions

Event